Mice lacking glutamate carboxypeptidase II are protected from peripheral neuropathy and ischemic brain injury

Journal of Neurochemistry

Volumn 95, Issue 2, 2005, Pages 314-323

  Bacich, Dean J ^a   Wozniak, Krystyna M ^b   Lu, X C May ^b   O'Keefe, Denize S ^a   Callizot, Noelle ^c   Heston, Warren D W ^d   Slusher, Barbara S ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b GUILFORD PHARMACEUTICALS INC   (United States)

^c Neurofit SAS   (France)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Folate hydrolase; Glutamate carboxypeptidase II; Knockout mouse; N acetylated linked acidic dipeptidase; Prostate specific membrane antigen; Stroke

Indexed keywords

GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMIC ACID; HYDROLASE; N ACETYLASPARTYLGLUTAMIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; COGNITION; DISEASE PREDISPOSITION; ENZYME ACTIVITY; ENZYME DEFICIENCY; GASTROCNEMIUS MUSCLE; GENE DISRUPTION; HISTOLOGY; HOT PLATE TEST; KNOCKOUT MOUSE; LOCOMOTION; MAZE TEST; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR COORDINATION; MOUSE; MUSCLE ACTION POTENTIAL; NERVE CELL LESION; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PASSIVE AVOIDANCE; PERIPHERAL NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; SCIATIC NERVE; STROKE;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN ISCHEMIA; ELECTROPHYSIOLOGY; GLUTAMATE CARBOXYPEPTIDASE II; INFARCTION, MIDDLE CEREBRAL ARTERY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; NERVE CRUSH; PERIPHERAL NERVOUS SYSTEM DISEASES; PHENOTYPE; PSYCHOMOTOR PERFORMANCE; SCIATIC NERVE;

EID: 26844488305     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03361.x     Document Type: Article

References (55)

1. Albers G. W., Goldstein L. B., Hall D. and Lesko L. M. (2001) Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial. JAMA 286, 2673-2682.
2. Azzouz M., Kenel P. F., Warter J. M., Poindron P. and Borg J. (1996) Enhancement of mouse sciatic nerve regeneration by the long chain fatty alcohol, N-Hexacosanol. Exp Neurol. 138, 189-197.
3. Bacich D. J., Ramadan E., O'Keefe D. S. et al. (2002). Deletion of the glutamate carboxypeptidase II gene in mice reveals a second enzyme activity that hydrolyzes N-acetylaspartylglutamate. J Neurochem. 83, 20-29.
4. Blakely R. D., Robinson M. B., Thompson R. C., Coyle J. T. (1988) Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate: subcellular and regional distribution, ontogeny, and the effect of lesions on N-acetylated-alpha-linked acidic dipeptidase activity. J Neurochem. 50, 1200-1209.
5. Boissier J. R. and Simon P. (1965) Action of caffeine on the spontaneous motility of the mouse. Arch. Int. Pharmacodyn Ther 158, 212-221.
6. Bruno V., Wroblewska B., Wroblewski J. T., Fiore L. and Nicoletti F. (1998) Neuroprotective activity of N-acetylaspartylglutamate in cultured cortical cells. Neuroscience 85, 751-757.
7. Bzdega T., Crowe S. L., Ramadan E. R., Sciarretta K. H., Olszewski R. T., Ojeifo O. A., Rafalski V. A., Wroblewska B. and Neale J. H. (2004) The cloning and characterization of a second brain enzyme with NAAG peptidase activity. J. Neurochem. 89, 627-635.
8. Chang S. S., O'Keefe D. S., Bacich D. J., Reuter V. E., Heston W D. and Gaudin P. B. (1999) Prostate-specific membrane antigen is produced in tumor-associated neovasculature. Clin. Cancer Res. 5, 2674-2681.
9. Chen S. R., Wozniak K. M., Slusher B. S. and Pan H. L. (2002) Effect of 2-(phosphono-methyl)-pentanedioic acid on allodynia and afferent ectopic discharges in a rat model of neuropathic pain. J. Pharmacol. Exp Ther 300, 662-667.
10. Choi D. W., Maulucci-Gedde M. and Kriegstein A. R. (1987) Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7, 357-368.
11. D'Adamo A. F., Smith J. C. and Woiler (1973) The occurrence of N-acetylasparate amidohydrolase (aminoacyclase II) in the developing rat. J. Neurochem. 20, 1275-1278.
12. Dunham N. W. and Miya T. S. (1957) A note on a simple apparatus for detecting neurological deficit in rats and mice. J. Am. Pharm. Ass. 46, 208-209.
13. Eddy N. B. and Leimbach D. (1953) Synthetic analgesics: II dithienylbutenyl and dithienylbutylamines. J. Pharmacol. Exp. Ther. 107, 385-393.
14. Ernst T., Hergenhahn M., Kenzelmann M. et al. (2002) Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue. Am. J. Pathol 160, 2169-2180.
15. Forrest D., Yuzaki M., Soares H. D., Ng L., Luk D. C., Sheng M., Stewart C. L., Morgan J. I., Connor J. A. and Curran T. (1994) Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death. Neuron 13, 325-338.
16. Ghadge G. D., Slusher B. S., Bodner A. et al. (2003) Glutamate carboxypeptidase II inhibition protects motor neurons from death in familial amyotrophic lateral sclerosis models. Proc. Natl Acad. Sci. USA 100, 9554-9559.
17. Glick S. D. and Zimmerberg B. (1972) Amnesic effects of scopolamine. Behav. Biol. 7, 245-254.
18. Guarda A. S., Robinson M. B., Ory-Lavollee L., Forloni G. L., Blakely R. D. and Coyle J. T. (1988) Quantitation of N-acetyl-aspartyl-glutamate in microdissected rat brain nuclei and peripheral tissues: findings with a novel liquid phase radioimmunoassay. Brain Res. 427, 223-231.
19. Handley S. L. and Mithani S. (1984) Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn Schmiedebergs Arch. Pharmacol. 327, 1-5.
20. Harada C., Harada T., Slusher B. S., Yoshida K., Matsuda H. and Wada K. (2000) N-acetylated-alpha-linked-acidic dipeptidase inhibitor has a neuroprotective effect on mouse retinal ganglion cells after pressure-induced ischemia. Neurosci. Lett. 292, 134-136.
21. Irwin S. (1968) Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia 13, 222-257.
22. Israeli R. S., Powell C. T., Corr J. G., Fair W. R. and Heston W. D. (1994) Expression of the prostate-specific membrane antigen. Cancer Res. 54, 1807-1811.
23. Jackson P. F., Tays K. L., Maclin K. M. et al. (2001) Design and pharmacological activity of phosphinic acid based NAALADase inhibitors. J. Med. Chem. 44, 4170-4175.
24. Lu X., Tang Z., Liu W., Lin Q. and Slusher B. S. (2000) N-acetyl-aspartate-glutamate (NAAG) protects against focal cerebral ischemia in rats. Eur. J. Pharmacol. 408, 233-239.
25. Luthi-Carter R., Barczak A. K., Speno H. and Coyle J. T. (1998) Molecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase). J. Pharmacol. Exp. Ther. 286, 1020-1025.
26. Madhavarao C. N., Moffett J. R., Moore R. A., Viola R. E., Namboodiri M. A. and Jacobowitz D. M. (2004) Immunohistocheical localization of aspartoacylase in the rat central nervous system. J. Comp. Neurol. 472, 318-329.
27. McKinzie D. L., Li T.-K., McBride W. J. and Slusher B. S. (2000) NAALADase inhibition reduces alcohol consumption in the alcohol-preferring (P) line of rats. Addiction Biol. 5, 411-416.
28. Mead A. N. and Stephens D. N. (2003) Selective disruption of stimulus-reward learning in glutamate receptor grial knock-out mice. J. Neurosci. 23, 1041-1048.
29. Morris R. (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11, 47-60.
30. Neale J. H., Bzdega T. and Wroblewska B. (2000) N-acetylaspartyl- glutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system. J. Neurochem. 75, 443-452.
31. O'Keefe D. S., Bacich D. J. and Heston W. D. (2004) Comparative analysis of prostate-specific membrane antigen (PSMA) versus a prostate-specific membrane antigen-like gene. Prostate 58, 200-210.
32. Olszewski R. T., Bukhari N., Zhou J. et al. (2004) NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR. J. Neurochem. 89, 876-885.
33. Orlando L. R., Luthi-Carter R., Standaert D. G., Coyle J. T., Penney J. B. Jr and Young A. B. (1997) N-acetyl-aspartylgluatmate (NAAG) protects against rat striatal quinolinic acid lesions in vivo. Neurosci. Lett. 236, 91-94.
34. Popik P., Kozela E., Wrobel M., Wozniak K. M. and Slusher B. S. (2003) Morphine tolerance and reward but not expression of morphine dependence are inhibited by the selective glutamate carboxypeptidase II (GCP II, NAALADase) inhibitor, 2-PMPA. Neuropsychopharmacology 28, 457-467.
35. Porsolt R. D., Bertin A. and Jalfre M. (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229, 327-336.
36. Pujol A., Ferrer I., Camps C., Metzger E., Hindelang C., Callizot N., Ruiz M., Pampols T., Giros M. and Mandel J. L. (2004) Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. Hum. Mol. Genet. 13, 2997-3006.
37. Rawlings N. D. and Barrett A. J. (1997) Structure of membrane glutamate carboxypeptidase. Biochim. Biophys. Acta 1339, 247-252.
38. Robinson M. B., Blakely R. D., Couto R. and Coyle J. T. (1987) Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. J. Biol. Chem. 262, 14 498-14 506.
39. Shippenberg T. S., Rea W. and Slusher B. S. (2000) Modulation of behavioral sensitization to cocaine by NAALADase inhibition. Synapse 38, 161-166.
40. Slusher B. S., Robinson M. B., Tsai G., Simmons M. L., Richards S. S. and Coyle J. T. (1990) Rat brain N-acetylated alpha-linked acidic dipeptidase activity. Purification and immunologic characterization. J. Biol. Chem. 265, 21 297-21 301.
41. Slusher B. S., Vornov J. J., Thomas A. G. et al. (1999) Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury. Nat. Med. 5, 1396-1402.
42. Slusher B. S., Thomas A., Paul M., Schad C. A. and Ashby C. R. Jr (2001) Expression and acquisition of the conditioned place preference response to cocaine in rats is blocked by selective inhibitors of the enzyme N-acetylated-alpha-linked-acidic dipeptidase (NAALADASE). Synapse 41, 22-28.
43. Soubrie P., Kulkarni S., Simon P. and Boissier J. R. (1975) Effects of antianxiety drugs on the food intake in trained and untrained rats and mice. Psychopharmacologia 45, 203-210.
44. Swinyard E. A., Brown W. C. and Goodman L. S. (1952) Comparative assays of antiepileptic drugs in mice and rats. J. Pharmacol. Exp. Ther. 106, 319-330.
45. Thomas A. G., Vornov J. J., Olkowski J. L., Merion A. T. and Slusher B. S. (2000) N-acetylated-α-linked acidic dipeptidase converts N-acetyl-aspartyl-glutamate from a neuroprotectant to a neurotoxin. J. Pharmacol. Exp. Ther. 295, 16-22.
46. Thomas A. G., Olkowski J. L. and Slusher B. S. (2001) Neuroprotection afforded by NAAG and NAALADase inhibition requires glial cells and metabotropic glutamate receptor activation. Eur. J. Pharmacol. 426, 35-38.
47. Tortella F. C., Lin Y., Ved H., Slusher B. S. and Dave J. R. (2000) Neuroprotection produced by the NAALADase inhibitor 2-PMPA in rat cerebellar neurons. Eur. J. Pharmacol. 402, 31-37.
48. Tsai G., Stauch B. L., Vornov J. J., Deshpande J. K. and Coyle J. T. (1990) Selective release of N-acetylaspartylglutamate from rat optic nerve terminals in vivo. Brain Res. 518, 313-316.
49. Tsai G., Dunham K. S., Drager U., Grier A., Anderson C., Collura J. and Coyle J. T. (2003) Early embryonic death of glutamate carboxypeptidase II (NAALADase) homozygous mutants. Synapse 50, 285-292.
50. Urazaev A. K., Buttram J. G. Jr, Deen J. P., Gafurov B. S., Slusher B. S., Grossfeld R. M. and Lieberman E. M. (2001) Mechanisms for clearance of released N-acetylasparrylglutamate in crayfish nerve fibers: implications for axon-glia signaling. Neuroscience 107, 697-703.
51. Wozniak K., Callizot N., Poindron P. and Slusher B. (2000) NAALADase inhibition enhances behavioral and morphological recovery following sciatic nerve crush in mice. Soc. Neurosci. Abstr. 43, 11
52. Wroblewska B., Santi M. R. and Neale J. H. (1998) N- acetylaspartylglutamate activates cyclic AMP-coupled metabotropic glutamate receptors in cerebellar astrocytes. Glia 24, 172-179.
53. Yamamoto T., Hirasawa S., Wroblewska B., Grajkowska E., Zhou J., Kozikowski A., Wroblewski J. and Neale J. H. (2004) Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in rat neuropathic pain model. Eur. J. Neurosci. 20, 483-494.
54. Zhang W., Slusher B., Murakawa Y., Wozniak K. M., Tsukamoto T., Jackson P. F. and Sima A. A. (2002) GCPII (NAALADase) inhibition prevents long-term diabetic neuropathy in type 1 diabetic BB/Wor rats. J. Neurol. Sci. 194, 21-28.
55. Zhong C., Zhao X., Sarva J., Kozikowski A. and Neale J. H. (2005) NAAG peptidase inhibitor reduces acute neuronal degeneration and astrocyte damage following lateral fluid perfusion TBI in rats. J. Neurotrauma 22, 266-276.